China Resources Boya Bio pharmaceutical Group Co Ltd
SZSE:300294
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
China Resources Boya Bio pharmaceutical Group Co Ltd
China Resources Boya Bio pharmaceutical Group Co Ltd
Other Liabilities
China Resources Boya Bio pharmaceutical Group Co Ltd
Other Liabilities Peer Comparison
6160
1801
603392
300122
300896
Competitive Other Liabilities Analysis
Latest Figures & CAGR of Competitors
| Company | Other Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
China Resources Boya Bio pharmaceutical Group Co Ltd
SZSE:300294
|
Other Liabilities
¥23.5m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
21%
|
|
|
Beigene Ltd
HKEX:6160
|
Other Liabilities
¥1.6B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
Innovent Biologics Inc
HKEX:1801
|
Other Liabilities
¥1.2B
|
CAGR 3-Years
24%
|
CAGR 5-Years
21%
|
CAGR 10-Years
N/A
|
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Other Liabilities
¥33.6m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Other Liabilities
¥228.3m
|
CAGR 3-Years
3%
|
CAGR 5-Years
20%
|
CAGR 10-Years
15%
|
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Other Liabilities
¥4.1m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
N/A
|
See Also
What is China Resources Boya Bio pharmaceutical Group Co Ltd's Other Liabilities?
Other Liabilities
23.5m
CNY
Based on the financial report for Mar 31, 2024, China Resources Boya Bio pharmaceutical Group Co Ltd's Other Liabilities amounts to 23.5m CNY.
What is China Resources Boya Bio pharmaceutical Group Co Ltd's Other Liabilities growth rate?
Other Liabilities CAGR 10Y
21%
Over the last year, the Other Liabilities growth was -10%. The average annual Other Liabilities growth rates for China Resources Boya Bio pharmaceutical Group Co Ltd have been -9% over the past three years , -9% over the past five years , and 21% over the past ten years .
You don't have any saved screeners yet
